Dionysia Amanatidou

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Ischemia Reperfusion Injury

Reactive Oxygen Species

Top Venues

Journal of xenobiotics

Medicines (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Stavroula Ioannidou, Konstantina Kazeli, Hristos Ventouris, Dionysia Amanatidou, Argyrios Gkinoudis, Evgenia Lymperaki
Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study. Journal of xenobiotics 13 (2) (2023)
Stavroula Ioannidou, Konstantina Kazeli, Hristos Ventouris, Dionysia Amanatidou, Argyrios Gkinoudis, Evgenia Lymperaki
Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study. Journal of xenobiotics 13 (2) (2023)
Stavroula Ioannidou, Konstantina Kazeli, Hristos Ventouris, Dionysia Amanatidou, Argyrios Gkinoudis, Evgenia Lymperaki
Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study. Journal of xenobiotics 13 (2) (2023)
Stavroula Ioannidou, Konstantina Kazeli, Hristos Ventouris, Dionysia Amanatidou, Argyrios Gkinoudis, Evgenia Lymperaki
Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study. Journal of xenobiotics 13 (2) (2023)
Stavroula Ioannidou, Konstantina Kazeli, Hristos Ventouris, Dionysia Amanatidou, Argyrios Gkinoudis, Evgenia Lymperaki
Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study. Journal of xenobiotics 13 (2) (2023)
Ioannis Tsamesidis, Farnoush Mousavizadeh, Chinedu Ogbonnia Egwu, Dionysia Amanatidou, Antonella Pantaleo, Françoise Benoit-Vical, Karine Reybier, Athanassios Giannis
In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative. Medicines (Basel, Switzerland) 9 (2) (2022)